Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.

Chronic inflammation and oxidative stress are striking features of Duchenne muscular dystrophy disease. Diacerhein is an anthraquinone, which exhibits anti-inflammatory and antioxidant properties. Based on their actions, the present study evaluated the effects of diacerhein against myonecrosis, oxid...

Full description

Saved in:
Bibliographic Details
Main Authors: Rafael Dias Mâncio, Túlio de Almeida Hermes, Aline Barbosa Macedo, Daniela Sayuri Mizobuti, Ian Feller Rupcic, Elaine Minatel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182449&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850076478134288384
author Rafael Dias Mâncio
Túlio de Almeida Hermes
Aline Barbosa Macedo
Daniela Sayuri Mizobuti
Ian Feller Rupcic
Elaine Minatel
author_facet Rafael Dias Mâncio
Túlio de Almeida Hermes
Aline Barbosa Macedo
Daniela Sayuri Mizobuti
Ian Feller Rupcic
Elaine Minatel
author_sort Rafael Dias Mâncio
collection DOAJ
description Chronic inflammation and oxidative stress are striking features of Duchenne muscular dystrophy disease. Diacerhein is an anthraquinone, which exhibits anti-inflammatory and antioxidant properties. Based on their actions, the present study evaluated the effects of diacerhein against myonecrosis, oxidative stress and inflammatory response in the diaphragm muscle of mdx mice and compared these results to current treatment widely used in DMD patients, with a main focus on the impact of prednisone. The results demonstrated that diacerhein treatment prevented muscle damage indicated by a decrease in the IgG uptake by muscle fibers, lower CK levels in serum, reduction of fibers with central nuclei with a concomitant increase in fibers with peripheral nuclei. It also had an effect on the inflammatory process, decreasing the inflammatory area, macrophage staining and TNF-α and IL-1β content. Regarding oxidative stress, diacerhein treatment was effective in reducing the ROS and lipid peroxidation in the diaphragm muscle from mdx mice. Compared to prednisone treatment, our findings demonstrated that diacerhein treatment improved the dystrophic phenotype in the diaphragm muscle of mdx mice similar to that of glucocorticoid therapy. In this respect, this work suggests that diacerhein has a potential use as an alternative drug in dystrophinopathy treatment and recommends that its anti-inflammatory and antioxidants properties in the dystrophic muscle should be better understood.
format Article
id doaj-art-4eaf80eceb2a49a196ff6446c8f42dd9
institution DOAJ
issn 1932-6203
language English
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-4eaf80eceb2a49a196ff6446c8f42dd92025-08-20T02:46:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018244910.1371/journal.pone.0182449Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.Rafael Dias MâncioTúlio de Almeida HermesAline Barbosa MacedoDaniela Sayuri MizobutiIan Feller RupcicElaine MinatelChronic inflammation and oxidative stress are striking features of Duchenne muscular dystrophy disease. Diacerhein is an anthraquinone, which exhibits anti-inflammatory and antioxidant properties. Based on their actions, the present study evaluated the effects of diacerhein against myonecrosis, oxidative stress and inflammatory response in the diaphragm muscle of mdx mice and compared these results to current treatment widely used in DMD patients, with a main focus on the impact of prednisone. The results demonstrated that diacerhein treatment prevented muscle damage indicated by a decrease in the IgG uptake by muscle fibers, lower CK levels in serum, reduction of fibers with central nuclei with a concomitant increase in fibers with peripheral nuclei. It also had an effect on the inflammatory process, decreasing the inflammatory area, macrophage staining and TNF-α and IL-1β content. Regarding oxidative stress, diacerhein treatment was effective in reducing the ROS and lipid peroxidation in the diaphragm muscle from mdx mice. Compared to prednisone treatment, our findings demonstrated that diacerhein treatment improved the dystrophic phenotype in the diaphragm muscle of mdx mice similar to that of glucocorticoid therapy. In this respect, this work suggests that diacerhein has a potential use as an alternative drug in dystrophinopathy treatment and recommends that its anti-inflammatory and antioxidants properties in the dystrophic muscle should be better understood.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182449&type=printable
spellingShingle Rafael Dias Mâncio
Túlio de Almeida Hermes
Aline Barbosa Macedo
Daniela Sayuri Mizobuti
Ian Feller Rupcic
Elaine Minatel
Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
PLoS ONE
title Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
title_full Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
title_fullStr Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
title_full_unstemmed Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
title_short Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.
title_sort dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182449&type=printable
work_keys_str_mv AT rafaeldiasmancio dystrophicphenotypeimprovementinthediaphragmmuscleofmdxmicebydiacerhein
AT tuliodealmeidahermes dystrophicphenotypeimprovementinthediaphragmmuscleofmdxmicebydiacerhein
AT alinebarbosamacedo dystrophicphenotypeimprovementinthediaphragmmuscleofmdxmicebydiacerhein
AT danielasayurimizobuti dystrophicphenotypeimprovementinthediaphragmmuscleofmdxmicebydiacerhein
AT ianfellerrupcic dystrophicphenotypeimprovementinthediaphragmmuscleofmdxmicebydiacerhein
AT elaineminatel dystrophicphenotypeimprovementinthediaphragmmuscleofmdxmicebydiacerhein